EFTA Document EFTA01361373
OCH-ZIFF Och-Ziff Professional Biographies CAPITAL MANAGEMENT GROUP ICS Investment Committee David Windreich is Head of U.S. and European Investing for Och-Ziff and is a member of OZM's Board of Directors and Partner Management Committee. Mr. Windreich is also an Executive Managing Director. Prior to joining Och-Ziff at its inception in 1994, Mr. Windreich was a Vice President in the Equity Derivatives Department of Goldman, Sachs & Co. He began his career at Goldman, Sachs & Co. in 1983
Summary
OCH-ZIFF Och-Ziff Professional Biographies CAPITAL MANAGEMENT GROUP ICS Investment Committee David Windreich is Head of U.S. and European Investing for Och-Ziff and is a member of OZM's Board of Directors and Partner Management Committee. Mr. Windreich is also an Executive Managing Director. Prior to joining Och-Ziff at its inception in 1994, Mr. Windreich was a Vice President in the Equity Derivatives Department of Goldman, Sachs & Co. He began his career at Goldman, Sachs & Co. in 1983
Ask AI About This Document
Extracted Text (OCR)
Related Documents (6)
HOUSE OVERSIGHT 016696-Palm-Beach
November 12, 2025 release of Jeffrey Epstein documents by the House Committee on Oversight and Government Reform. Microsoft Excel Spreadsheets converted to PDF. Originals in NATIVES/001 folder
EFTA Document EFTA01378283
OCH-ZIFF Och-Ziff Professional Biographies CAPITAL MANAGEMENT GROUP ICS Investment Committee David Windreich is Head of U.S. and European Investing for Och-Ziff and is a member of OZM's Board of Directors and Partner Management Committee. Mr. Windreich is also an Executive Managing Director. Prior to joining Och-Ziff at its inception in 1994, Mr. Windreich was a Vice President in the Equity Derivatives Department of Goldman, Sachs & Co. He began his career at Goldman, Sachs & Co. in 1983
17 August 1 through August 15 2016_Redacted.pdf
JAN 1 2 3 4 7a to 12p 0 4 0 7 1p to 5p 1 3 0 5 6p to 12a 2 0 1 10 1a to 6a 0 0 0 0 AVER 1 2 0 6 total 3 7 1 22 Year to date searches 5 7 12 9 4 8 32 6 26 8 3 2 10 39 7 18 7 8 0 8 33 763 8 18 5 3 2 7 28 9 4 4 0 0 2 8 10 0 0 0 0 0 0 11 12 3 1 0 4 16 12 13 16 23 20 17 3 2 0 7 10 12 39 49 Jan 14 15 16 17 11 20 4 1 19 15 3 0 3 7 0 0 0 0 0 4 8 11 2 1 33 42 7 5 Month Average 18 7 9 1 0 4 17 19 20 21 9 22 14 11 16 9 9 2 1 0 0 4 7 10 7 29 40 28 190.75 22 14 13 1 0 7 28 23 24 25 26 27 28 4 0
FBI USAMRID Investigation
011621Anthrax Page 1 of 1446 o I 2792\-WF-222936-'-USAMRIID - \\OC o I [he followijg investigation was conducted by Special Agent (SA)_ _of the federal Bureau of Investigation (FBI) on February 24, 2005: ? The United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Keycard Access records from 1998 through 2002 were queried f r v' ? ? ? scientist nd visitin scient'st both ?rom the who have p eviously been identified as visiting USAMRIID circa May 1998. ;11 available
NAME SEARCHED: Mort, Inc
DOJ EFTA Data Set 10 document EFTA01295633
EFTA Document EFTA01470762
Deutsche Asset & Wealth Management Key Client Partners — U.S. Investment Themes and Solutions September 2014 For Internal Use Only Participant Dial-In: (877) 500-9123 International Dial In: (973) 796-5004 Conference ID: 9048-0259 Encore Dates: 9/10 — 9/30/2014 USA Free Call: (866) 247-4222 Conference ID: 9048-0259 U.S. Key Client Partner opportunities are available to Institutional Investors only. EFTA01470762 A global partner for our clients Deutsche Bank A leading global fin
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.